PFSCM has been serving the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) project since 2016.
In 2016, Gilead Sciences Inc. granted PFSCM more than $6 million to procure and distribute pre-exposure prophylaxis (PrEP) tablets on behalf of the DREAMS partnership in several sub-Saharan African countries.
The DREAMS program provides a comprehensive, multi-sectoral package of core interventions to address critical factors that make girls and young women particularly vulnerable to HIV.
Since 2014, PFSCM has sourced, quality-tested, and coordinated the delivery of over 680 000 packs of essential HIV -preventing PrEP tablets – enough to treat about 56,515 people a year.
Shipping PrEP to eight African countries, including Botswana, Kenya, Malawi, Namibia, South Africa, Swaziland, Zambia, and Zimbabwe. Most recently, South Africa increased its PrEP service points from 49 to over 140.
In 2021, PFSCM shipped almost $300,000 worth of HIV drugs to Zambia, $132,000 to Malawi, and $835,000 to South Africa on behalf of the DREAMS program.
Together in close cooperation with leading freight forwarders, donors, and principal recipients, PFSCM contributes to the continued success of the DREAMS program.
Since the onset, 202 546 young females between the ages of 15-24 have received packs of Emtricitabine/Tenofovir Disoproxil Fumarate 200/300mg (TE).
As the principal procurement agent for the DREAMS program, PFSCM is proud to be part of a program that transforms young women’s lives, supporting them to live more stable and healthier lives.